GlassScriptPhysician profile
Adam Vandenlangenberg
NPI 1992384465
$3,156.63
in general payments reported to CMS, 2019-2025
9 companies · $2,051 in 2025
The $2,051 reported for 2025 was more than what 80% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $299 · 2023: $226 · 2024: $457 · 2025: $2,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747 · Travel and Lodging: $986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.86 |
| Travel and Lodging | $986.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,684.17 | 2022-2025 | Durysta |
| Alcon Vision LLC | $478.04 | 2023-2024 | Clareon, Centurion |
| Sight Sciences, INC. | $295.26 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| New World Medical,INC. | $264.94 | 2025 | Streamline, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Janssen Pharmaceuticals, INC | $124.99 | 2021 | |
| Bausch & Lomb Americas INC. | $105.25 | 2025 | Envista Envy Iol |
| Glaukos Corporation | $102.02 | 2025 | Idosetr, Istent Infinite |
| Allergan, INC. | $74.29 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $27.67 | 2025 | Tecnis Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Vandenlangenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.